ETF Managers Group, LLC Vascular Biogenics Ltd. Transaction History

ETF Managers Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 01, 2019	SELL	$0.6 - $1.72 $42,668 - $122,316	-71,114 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$1.55 - $2.17 $110,226 - $154,317	71,114 New	71,114 $116,000
Q2 2018 Aug 14, 2018	SELL	$2.05 - $3.0 $40,208 - $58,842	-19,614 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.27 - $8.5 $7,418 - $27,778	3,268 Added 19.99%	19,614 $43,000
Q4 2017 Feb 14, 2018	BUY	$5.65 - $9.0 $4,017 - $6,399	711 Added 4.55%	16,346 $118,000
Q3 2017 Nov 14, 2017	BUY	$4.15 - $7.2 $64,885 - $112,572	15,635	15,635 $95,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.